| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |